Ardelyx, Inc. (ARDX) stock
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.12−0.06 (-1.89%)
Close on Nov 18, 2026Market cap $777.47MP/E –Yield –
Ardelyx revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Ardelyx's revenue for the twelve months ending Jun 30, 2026 was $450.89M, up 16.8% year over year. For fiscal 2025 it was $407.32M, up 22.1% from the year before. Over ten years it grew 29.1% a year on average. The highest annual figure on record is $407.32M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $407.32M | +22.1% |
| FY2024 | Dec 31, 2024 | $333.62M | +168.1% |
| FY2023 | Dec 31, 2023 | $124.46M | +138.6% |
| FY2022 | Dec 31, 2022 | $52.16M | +416.6% |
| FY2021 | Dec 31, 2021 | $10.10M | +33.4% |
| FY2020 | Dec 31, 2020 | $7.57M | +43.4% |
| FY2019 | Dec 31, 2019 | $5.28M | +102.6% |
| FY2018 | Dec 31, 2018 | $2.61M | -93.8% |
| FY2017 | Dec 31, 2017 | $42.00M | +74.8% |
| FY2015 | Dec 31, 2015 | $24.03M | -24.0% |
| FY2014 | Dec 31, 2014 | $31.62M | +9.3% |
| FY2013 | Dec 31, 2013 | $28.93M | +434.7% |
| FY2012 | Dec 31, 2012 | $5.41M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $120.88M | +23.8% |
| Q1 FY2026 | Mar 31, 2026 | $94.47M | +27.5% |
| Q4 FY2025 | Dec 31, 2025 | $125.22M | +7.8% |
| Q3 FY2025 | Sep 30, 2025 | $110.33M | +12.3% |
| Q2 FY2025 | Jun 30, 2025 | $97.66M | +33.4% |
| Q1 FY2025 | Mar 31, 2025 | $74.11M | +61.0% |
| Q4 FY2024 | Dec 31, 2024 | $116.13M | +237.9% |
| Q3 FY2024 | Sep 30, 2024 | $98.24M | +74.2% |
| Q2 FY2024 | Jun 30, 2024 | $73.22M | +227.9% |
| Q1 FY2024 | Mar 31, 2024 | $46.02M | +304.8% |
| Q4 FY2023 | Dec 31, 2023 | $34.36M | -22.2% |
| Q3 FY2023 | Sep 30, 2023 | $56.39M | +1031.0% |
| Q2 FY2023 | Jun 30, 2023 | $22.33M | +784.1% |
| Q1 FY2023 | Mar 31, 2023 | $11.37M | +2329.3% |
| Q4 FY2022 | Dec 31, 2022 | $44.18M | +4193.3% |
| Q3 FY2022 | Sep 30, 2022 | $4.99M | +325.1% |
| Q2 FY2022 | Jun 30, 2022 | $2.53M | +92.4% |
| Q1 FY2022 | Mar 31, 2022 | $468.00K | -92.9% |
| Q4 FY2021 | Dec 31, 2021 | $1.03M | -43.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.17M | -56.8% |
| Q2 FY2021 | Jun 30, 2021 | $1.31M | -28.5% |
| Q1 FY2021 | Mar 31, 2021 | $6.58M | +442.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.81M | -19.6% |
| Q3 FY2020 | Sep 30, 2020 | $2.71M | -10.0% |
| Q2 FY2020 | Jun 30, 2020 | $1.84M | +10100.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.21M | +1327.1% |
| Q4 FY2019 | Dec 31, 2019 | $2.25M | +1208.1% |
| Q3 FY2019 | Sep 30, 2019 | $3.01M | +9943.3% |
| Q2 FY2019 | Jun 30, 2019 | $18.00K | -99.2% |
| Q4 FY2018 | Dec 31, 2018 | $85.00K | -99.8% |
| Q3 FY2018 | Sep 30, 2018 | $172.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $30.00K | – |
| Q1 FY2018 | Mar 31, 2018 | $2.32M | – |
| Q4 FY2017 | Dec 31, 2017 | $42.00M | – |
See a number that looks wrong?